• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Cabometyx (cabozantinib) - Articles and news items

renal cell carcinoma

Ipsen’s kidney cancer drug receives positive CHMP and ‘Promising Innovative Medicine’ status

Industry news / 25 July 2016 / Niamh Louise Marriott, Digital Content Producer

Ipsen announced that CHMP & EMA have provided a positive opinion for Cabometyx for the treatment of advanced renal cell carcinoma (RCC) in adults…

 

Win an Amazon Gift Card worth up to €100!TAKE OUR SURVEY
+ +